Diet Pills Redux
- 28 August 1997
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 337 (9) , 629-630
- https://doi.org/10.1056/nejm199708283370909
Abstract
Between 1967 and 1972, there was a serious outbreak of primary pulmonary hypertension in Western Europe.1 The incidence of the disorder among patients seen at major cardiac catheterization centers in Switzerland, Germany, and Austria increased by a factor of 10. This unusual epidemic was traced to the use of an appetite-suppressant drug, aminorex (Menocil), which had been introduced in Europe shortly before. The drug was quickly withdrawn from the market, but not before it had resulted in substantial morbidity and a mortality rate of 50 percent among affected patients. Postmortem examinations in fatal cases disclosed obstructive lesions in the muscular . . .Keywords
This publication has 8 references indexed in Scilit:
- Valvular Heart Disease Associated with DexfenfluramineNew England Journal of Medicine, 1997
- Further Cases of Valvular Heart Disease Associated with Fenfluramine–PhentermineNew England Journal of Medicine, 1997
- Fatal Pulmonary Hypertension Associated with Short-Term Use of Fenfluramine and PhentermineNew England Journal of Medicine, 1997
- Valvular Heart Disease Associated with Fenfluramine–PhentermineNew England Journal of Medicine, 1997
- Anorexic Agents Aminorex, Fenfluramine, and Dexfenfluramine Inhibit Potassium Current in Rat Pulmonary Vascular Smooth Muscle and Cause Pulmonary VasoconstrictionCirculation, 1996
- Appetite-Suppressant Drugs and the Risk of Primary Pulmonary HypertensionNew England Journal of Medicine, 1996
- Primary pulmonary hypertension and fenfluramine use.Heart, 1993
- Variability of Body Weight and Health Outcomes in the Framingham PopulationNew England Journal of Medicine, 1991